[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fjeQw-b2f2OgqiCMNcS-vzUrZd_ujTuVEXnl2clP2B8w":8,"$fs0mpyNpE1FKFpBLRapXN76B9qUPoH5Y2jK13Yw5QMFA":55,"$fI6WNoZpzvYLrADbPD0iRU0X_fW29zpvxhQ57lFEB9sc":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66620,868989,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","文建华","浙江省医疗健康集团杭州医院","肿瘤科","主治医师",157,0,"肝内胆管癌健康科普指南","","https://ystcdn.venuertc.com/venue/AI/c72d645f-2f82-490a-b87c-c780021a5bed.jpg","\u003Cdiv id=\"material_title\" class=\"cholangiocarcinoma-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肝内胆管癌健康科普指南\u003C/h2>\n  \u003Cp class=\"cholangiocarcinoma-intro\">\n    有时候，肝脏的问题不像感冒那样容易被察觉。和家人闲聊时有人提到「最近总觉得没精神，还瘦了」，其实这样的信号可能藏着更深的健康隐患。肝内胆管癌，虽不常见，却是不能忽视的一种恶性肿瘤。本文带你用最简单的话，真正了解这个疾病，该注意什么，又该怎么行动。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section01\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    01 什么是肝内胆管癌？\n    \u003Cspan class=\"cholangiocarcinoma-bg1\">🍃\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg1\">\n    \u003Cp>\n      肝内胆管癌是一种发生在肝脏里的胆管上的恶性肿瘤。肝脏，就像一个不停运作的工厂，而胆管则是里头运送胆汁的重要管道。一旦这些管道里的细胞出了问题，异常增生成瘤，就会影响胆汁正常流动。这疾病发展较快，影响不仅限于肝脏本身，还可能逐渐扩散到周围组织。\n    \u003C/p>\n    \u003Cp>\n      简单来说，肝内胆管癌是肝脏内胆管中的“不速之客”，它会逐步阻碍胆汁通道，最终影响消化和肝脏整体健康。虽然它的发病率不像肝癌那么高，但由于发现时多已进展，治疗挑战较大。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section02\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    02 常见症状有哪些？😷\n    \u003Cspan class=\"cholangiocarcinoma-bg2\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg2\">\n    \u003Cp>\n      大多数情况下，早期肝内胆管癌的表现很隐匿。有些人只是在体检时碰巧发现肝脏有异常。偶尔会觉得身体有点虚弱，饭量小了或者莫名其妙地掉了几斤体重，这些变化非常轻微，不容易引发重视。\n    \u003C/p>\n    \u003Cp>\n      到了明显阶段，才会出现一些特别的症状：\u003C/p>\n    \u003Cul>\n      \u003Cli>\u003Cb>持续性的上腹隐痛：\u003C/b>不是偶尔疼，而是总觉得肚子上方涨涨难受。\u003C/li>\n      \u003Cli>\u003Cb>黄疸：\u003C/b>皮肤和眼白发黄，自己照镜子一看就能发现。\u003C/li>\n      \u003Cli>\u003Cb>持续疲劳：\u003C/b>不是一天两天，而是觉得怎么休息都提不起精神。\u003C/li>\n      \u003Cli>\u003Cb>体重显著下降：\u003C/b>不是饮食变少，而是短时间内明显瘦了。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      比如有位69岁的女性患者，刚开始只是腹部偶有不适，后来体检时发现肝脏有占位病变，最终诊断为肝内胆管癌并伴多处转移。这说明症状不明显时容易忽略，但出现持续性身体变化就需高度警觉。\n    \u003C/p>\n    \u003Cp>\n      这些症状并不绝对，每个人的表现可能略有不同。但如果发现自己或家人长时间存在上述情况，建议尽早就医，别拖延。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section03\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    03 为什么会得肝内胆管癌？🤔\n    \u003Cspan class=\"cholangiocarcinoma-bg3\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg3\">\n    \u003Cp>\n      肝内胆管癌的发生，主要涉及慢性疾病、基因和环境综合作用。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>慢性肝病：\u003C/b>长期的肝炎（尤其乙肝、丙肝）（Banales, J.M. et al., Nat. Rev. Gastroenterol. Hepatol., 2016），肝硬化患者尤其容易胆管细胞出现异常增生。慢性炎症让胆管微环境反复受损，就像长期工厂设备维护不好，容易出故障。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>胆管结石、胆囊结石：\u003C/b>反复炎症和石头摩擦，令胆管细胞受伤修复，变异风险增加（Bridgewater, J. et al., Annals of Oncology, 2014）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>遗传与基因突变：\u003C/b>有些人的家族里肿瘤发生率较高，这涉及胆管细胞基因异常。不是所有人都会遇到，但年龄增长后风险也随之增加。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>某些环境暴露：\u003C/b>比如长期接触特定化学物质、工业污染，也属于风险因素之一。虽然生活中不太常见，但对于从事此类工作的群体要留心。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      研究发现，60岁以上、原有肝病或者经常因胆系疾病接受治疗的人群，罹患肝内胆管癌的风险确实高于普通人群（Razumilava, N. & Gores, G.J., Gastroenterology, 2014）。\n    \u003C/p>\n    \u003Cp>\n      这些风险不是一时出现的，往往是多年累积。简单来讲，平时忽略肝胆健康，给疾病制造了机会。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section04\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    04 肝内胆管癌怎么诊断？🔍\n    \u003Cspan class=\"cholangiocarcinoma-bg4\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg4\">\n    \u003Cp>\n      如果临床怀疑存在肝内胆管问题，专业医生会根据病史、体征，加上现代医学检查方法进行诊断。目前主要依赖以下几类手段：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>影像学检查：\u003C/b>包括CT扫描、核磁共振（MRI）等。能清楚显示肝脏肿块的位置大小以及是否有转移迹象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>胆管镜检查：\u003C/b>通过内窥镜，直接观察胆管表面是否有异常增生或病灶。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>肝穿刺活检：\u003C/b>取肝脏小块组织做病理检查，确认是不是肿瘤细胞。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>实验室指标：\u003C/b>血清肿瘤标志物（如CA19-9、CEA等）辅助判断，但不能单独用于肝内胆管癌最终确诊。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      诊断过程比较系统，并不是单项指标决定。比如前文提到的病例，就是通过影像学和肝穿刺活检最终确诊的。医生会综合分析症状、检查结果，最后作出判断并制定治疗方案。\n    \u003C/p>\n    \u003Cp>\n      发现肝胆异常一定不要自行猜测，专业检查是最可靠的途径。早诊早治对于肝内胆管癌来说尤其关键。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section05\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    05 肝内胆管癌的治疗选择有哪些？🩺\n    \u003Cspan class=\"cholangiocarcinoma-bg5\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg5\">\n    \u003Cp>\n      目前治疗主要包括手术、药物（化疗/免疫治疗）、放疗和辅助医学支持。每种方案都有具体适应症，需医生根据个人情况量身定制。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>手术切除：\u003C/b>如果发现早期，肿瘤范围有限，可以考虑部分切除。术后还需观察是否有复发风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>化疗和免疫治疗：\u003C/b>对于无法手术或已有扩散者，药物治疗是主要方案。化疗通过注射和口服，联合免疫治疗，有时能显著控制病情进展（Valle, J.W. et al., N Engl J Med, 2010）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>辅助治疗：\u003C/b>贫血或消化道不适，可以配合使用专门药物进行缓解，但核心仍在控制肿瘤进展。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      比如上述69岁女性患者，经过联合化疗和免疫治疗，肝内转移灶明显缩小，淋巴结也有改善，病情稳定出院。说明在规范治疗下，肝内胆管癌可以得到有效控制，但需定期复查。\n    \u003C/p>\n    \u003Cp>\n      治疗选择会因人而异，重点在于早期发现并及时制定合理方案。不建议自行用药或盲目选择补品，始终与肿瘤科医生保持沟通。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section06\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    06 日常生活怎么降低肝内胆管癌风险？🏃\n    \u003Cspan class=\"cholangiocarcinoma-bg6\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg6\">\n    \u003Cp>\n      虽然无法完全避免风险，但日常生活的管理有助于减少肝内胆管癌的发生概率，也有利于整体健康。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>均衡饮食：\u003C/b>推荐多摄取新鲜蔬菜（如菠菜、胡萝卜）和高质量蛋白（鸡肉、鱼），帮助维持肝脏功能。\n        \u003Cspan class=\"cholangiocarcinoma-tips\">🍽️ [菠菜] + [护肝抗氧化] + [每餐加入适量生吃或快炒]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>坚持适量运动：\u003C/b>每周保持3~5天、每次30分钟的轻度运动，比如快走、太极，有助于增强免疫力、稳定体重。\n        \u003Cspan class=\"cholangiocarcinoma-tips\">👟 运动能促进全身代谢，有益肝胆健康。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>定期体检：\u003C/b>40岁以后可考虑每1-2年做一次肝胆超声检查，有慢性肝病的提前进行。\n        \u003Cspan class=\"cholangiocarcinoma-tips\">🔬 [超声检查] + [发现异常及时就医] + [避免拖延]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>管理基础疾病：\u003C/b>已有肝炎、结石等疾病，一定要规范治疗。避免病情反复加重，是保护肝胆健康的关键一步。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>保持心理健康：\u003C/b>情绪稳定、压力减少也对免疫系统有正面作用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      只要在日常中养成良好习惯，对肝内胆管癌的防护就多了一层保障。不是说完全可以预防，但能让风险降到最低，也提高整体生活质量。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section\">\n  \u003Ch2 id=\"section07\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    07 有疑问该怎么做？📞\n    \u003Cspan class=\"cholangiocarcinoma-bg7\">\u003C/span>\n  \u003C/h2>\n  \u003Cdiv class=\"cholangiocarcinoma-content-bg7\">\n    \u003Cp>\n      如果面对肝胆健康问题有疑惑，最好的办法是先去正规医疗机构咨询。尤其有明显症状时，不要拖延，首选综合性医院肝胆外科、肿瘤科或消化科进行检查和咨询。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>发现持续性疲劳、体重下降或黄疸，建议及时就医。\u003C/li>\n      \u003Cli>有肝胆结石、慢性肝病史的人群，应在医生指导下规律复查。\u003C/li>\n      \u003Cli>医疗选择时，看是否有相关资质和专业团队，避免听信民间偏方。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      其实，肝内胆管癌不是遥不可及的存在，了解基本知识并保持警觉，是对自己健康的最好负责方式。遇到不懂的情况，不妨和身边的专业人士谈谈，主动问诊才是关键。\n    \u003C/p>\n    \u003Cp>\n      身体上的小变化不要小看，医学技术在进步，生活习惯的调整同样重要。发现早、治疗及时，远比“担心过头”更靠谱。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"cholangiocarcinoma-section cholangiocarcinoma-ref\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    英文文献资料\n    \u003Cspan class=\"cholangiocarcinoma-bg-ref\">\u003C/span>\n  \u003C/h2>\n  \u003Cul>\n    \u003Cli>\n      Banales, J. M., et al. (2016). \"Cholangiocarcinoma: Current knowledge and future perspectives.\" \u003Ci>Nature Reviews Gastroenterology & Hepatology\u003C/i>, 13(5), 261–280. \u003Cbr>\n      \u003Cspan class=\"cholangiocarcinoma-ref-tips\">疾病机制与流行病学参考\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      Razumilava, N., & Gores, G. J. (2014). \"Cholangiocarcinoma.\" \u003Ci>Gastroenterology\u003C/i>, 146(6), 1216-1229. \u003Cbr>\n      \u003Cspan class=\"cholangiocarcinoma-ref-tips\">危险因素分析与临床进展\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      Bridgewater, J., et al. (2014). \"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.\" \u003Ci>Annals of Oncology\u003C/i>, 25(4), 755–770. \u003Cbr>\n      \u003Cspan class=\"cholangiocarcinoma-ref-tips\">临床诊断与管理建议\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      Valle, J. W., et al. (2010). \"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.\" \u003Ci>New England Journal of Medicine\u003C/i>, 362, 1273-1281. \u003Cbr>\n      \u003Cspan class=\"cholangiocarcinoma-ref-tips\">治疗方法和药物方案\u003C/span>\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n.cholangiocarcinoma-title {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  margin-top: 28px;\n  background-color: #eefcf8;\n  border-radius: 12px;\n  padding: 28px 40px;\n  box-shadow: 0 2px 10px rgba(80,160,120,0.05);\n  text-align: center;\n}\n.cholangiocarcinoma-intro {\n  color: #557250;\n  font-size: 1.18em;\n  margin: 16px auto;\n  line-height: 1.9;\n  max-width: 940px;\n}\n.cholangiocarcinoma-section {\n  margin: 38px auto;\n  max-width: 940px;\n  border-radius: 10px;\n  box-shadow: 0 1px 8px rgba(80,160,120,0.04);\n}\n.cholangiocarcinoma-section h2 {\n  font-family: \"Segoe UI\", \"Arial\", sans-serif;\n  font-weight: 600;\n  font-size: 1.38em;\n  color: #317964;\n  background: linear-gradient(90deg, #eafaf2 75%, #f8fbfc 100%);\n  border-radius: 10px 10px 0 0;\n  padding: 16px 24px 12px 24px;\n  position: relative;\n  margin-bottom: 0;\n  display: flex;\n  align-items: center;\n  border-left: 6px solid #3cc695;\n}\n.cholangiocarcinoma-bg1,\n.cholangiocarcinoma-bg2,\n.cholangiocarcinoma-bg3,\n.cholangiocarcinoma-bg4,\n.cholangiocarcinoma-bg5,\n.cholangiocarcinoma-bg6,\n.cholangiocarcinoma-bg7,\n.cholangiocarcinoma-bg-ref {\n  font-size: 1.65em;\n  margin-left: 9px;\n  opacity: .18;\n  filter: blur(0.6px);\n}\n\n.cholangiocarcinoma-content-bg1,\n.cholangiocarcinoma-content-bg2,\n.cholangiocarcinoma-content-bg3,\n.cholangiocarcinoma-content-bg4,\n.cholangiocarcinoma-content-bg5,\n.cholangiocarcinoma-content-bg6,\n.cholangiocarcinoma-content-bg7 {\n  background: linear-gradient(135deg, #f7fff9 55%, #fafef3 100%);\n  border-radius: 0 0 12px 12px;\n  padding: 28px 28px 16px 28px;\n  font-size: 1.09em;\n  color: #384f42;\n  line-height: 1.87;\n}\n.cholangiocarcinoma-content-bg2 ul,\n.cholangiocarcinoma-content-bg3 ul,\n.cholangiocarcinoma-content-bg4 ul,\n.cholangiocarcinoma-content-bg5 ul,\n.cholangiocarcinoma-content-bg6 ul,\n.cholangiocarcinoma-ref ul {\n  padding-left: 24px;\n  margin-top: 10px;\n  margin-bottom: 10px;\n}\n.cholangiocarcinoma-content-bg2 li,\n.cholangiocarcinoma-content-bg3 li,\n.cholangiocarcinoma-content-bg4 li,\n.cholangiocarcinoma-content-bg5 li,\n.cholangiocarcinoma-content-bg6 li,\n.cholangiocarcinoma-ref ul li {\n  margin-bottom: 9px;\n  line-height: 1.7;\n}\n.cholangiocarcinoma-content-bg2 b,\n.cholangiocarcinoma-content-bg3 b,\n.cholangiocarcinoma-content-bg4 b,\n.cholangiocarcinoma-content-bg5 b,\n.cholangiocarcinoma-content-bg6 b {\n  color: #237358;\n}\n.cholangiocarcinoma-tips {\n  display: inline-block;\n  background: #ecf8ef;\n  color: #2b7c62;\n  border-radius: 8px;\n  padding: 2px 11px;\n  margin-left: 10px;\n  font-size: .98em;\n}\n.cholangiocarcinoma-ref {\n  background: linear-gradient(100deg, #eefef4 85%, #fcfefe 100%);\n  border-radius: 12px;\n  box-shadow: 0 1px 8px rgba(80,170,120,0.04);\n  padding: 24px 36px 14px 36px;\n}\n.cholangiocarcinoma-ref h2 {\n  padding-bottom: 6px;\n  font-size: 1.13em;\n  color: #317964;\n  border-left: 6px solid #82dfc2;\n  background: linear-gradient(90deg, #eafaf2 75%, #f8fbfc 100%);\n  border-radius: 13px 13px 0 0;\n  margin-bottom: 0;\n  margin-top: 0;\n  display: flex;\n  align-items: center;\n}\n.cholangiocarcinoma-ref-tips {\n  color: #19543a;\n  font-size: .96em;\n  margin-top: 1px;\n  margin-bottom: 3px;\n  display: block;\n  padding-left: 9px;\n}\n@media screen and (max-width: 1000px) {\n  .cholangiocarcinoma-title, .cholangiocarcinoma-ref, .cholangiocarcinoma-section {\n    max-width: 97vw;\n    padding: 17px 3vw;\n  }\n  .cholangiocarcinoma-content-bg1,\n  .cholangiocarcinoma-content-bg2,\n  .cholangiocarcinoma-content-bg3,\n  .cholangiocarcinoma-content-bg4,\n  .cholangiocarcinoma-content-bg5,\n  .cholangiocarcinoma-content-bg6,\n  .cholangiocarcinoma-content-bg7 {\n    padding: 23px 12px 13px 12px;\n  }\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"cholangiocarcinoma-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); marg",518,"2025-09-17 14:08:10","肝内胆管癌, 胆管癌症状, 医疗诊断, 肝脏健康, 癌症治疗方案, 疾病预防, 早期发现肝癌, 肝病风险管理","了解肝内胆管癌的症状、诊断及治疗选择，早期识别有助于提高治疗效果并降低风险。关注肝胆健康，从本文获取专业知识。","2025-11-05 22:00:47",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]